In Vitro ELISA and Cell-Based Assays Confirm the Low Immunogenicity of VNAR Therapeutic Constructs in a Mouse Model of Human RA: An Encouraging Milestone to Further Clinical Drug Development. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1155/2020/7283239
PubMed Identifier: 32090129
Publication URI: http://europepmc.org/abstract/MED/32090129
Type: Journal Article/Review
Volume: 2020
Parent Publication: Journal of immunology research
ISSN: 2314-7156